We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Liver Surgery Boosts Bowel Cancer Survival Rate

By HospiMedica International staff writers
Posted on 16 Jun 2010
A new study shows that liver resection in patients with stage IV bowel cancer can boost five-year survival rate by almost 46%. More...


Researchers of the United Kingdom National Cancer Intelligence Network (NCIN; London) conducted a population-based study that followed 114,155 patients identified via the National Cancer Data Repository who underwent surgery for colorectal cancer between January 1998 and June 2004, of whom 3,116 (2.7%) subsequently had one or more hepatic resections; the hepatectomy rate increased from 1.7% in 1998 to 3.8% in 2004. All episodes of care in the 3 years after the initial operation were examined to determine the frequency of liver resection, and variations in the use of liver resection and survival were assessed.

The researchers found there was significant variation in the rate of liver resection across cancer networks and hospitals; the crude 5-year survival rate after liver resection was 44.2% from the time of hepatectomy and 45.9% from the time of colectomy. This was comparable to the 5-year survival rate of patients with stage III disease (42.2%). The study was published online on June 2, 2010, in the British Journal of Surgery.

"This surgery is very skilled and should be undertaken by expert surgeons working in specialist liver units,” said lead author Eva Morris, M.D., of the University of Leeds (United Kingdom). "We must work towards ensuring that all patients who need liver resections can access these services.”

Although first performed in 1943, the liver resection technique only became accepted practice in the mid 1990's, as initially it was very high-risk surgery. It ultimately became the gold standard treatment for bowel cancer that has spread to the liver in 2004.

Related Links:

United Kingdom National Cancer Intelligence Network
University of Leeds



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.